Efficacy and Safety of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations

NCT07054632 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Inherited Retinal Dystrophy Associated With RPE65 Mutations

Interventions

GENETIC: LX101

Sponsor

Innostellar Biotherapeutics Co.,Ltd